Lipitor and Melphalan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Melphalan (melphalan). Common drug interactions include pain among females and malignant melanoma among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Melphalan. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,050 Lipitor users. Check the latest studies of Lipitor.

What is Melphalan?

Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

44 people who take Lipitor and Melphalan together, and have interactions are studied.

Lipitor and Melphalan drug interactions.

What are the common drug interactions of Lipitor and Melphalan, by gender? *:

female:

  1. Pain
  2. Arthralgia (joint pain)
  3. Intervertebral disc degeneration (spinal disc degeneration)
  4. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  5. Osteomyelitis (infection of bone)
  6. Pain in extremity
  7. Dyspnoea (difficult or laboured respiration)
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Epistaxis (bleed from the nose)

male:

  1. Malignant melanoma (skin cancer rises from melancytes)
  2. Anaemia (lack of blood)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Iron deficiency anaemia
  5. Platelet count decreased
  6. White blood cell count decreased
  7. Cardiac failure congestive
  8. Confusional state
  9. Fatigue (feeling of tiredness)
  10. Leukopenia (less number of white blood cells in blood)

What are the common drug interactions of Lipitor and Melphalan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Bone disorder
  4. Deformity (disfigurement)
  5. Dyspnoea (difficult or laboured respiration)
  6. Emotional distress
  7. Fall
  8. Infection
  9. Leukopenia (less number of white blood cells in blood)
  10. Mucosal inflammation (infection of mucous membrane)

50-59:

  1. Decreased interest
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Endocarditis bacterial (an inflammation of the inner layer of the heart by bacterial infection)
  4. Fasciitis (infection of muscle surrounding tissue)
  5. Hypergammaglobulinaemia (elevated levels of gamma globulin)
  6. Hyperviscosity syndrome (a condition in which blood is not able to flow freely through your arteries)
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Intervertebral disc degeneration (spinal disc degeneration)
  9. Intervertebral disc space narrowing (spinal disc space narrowing)
  10. Joint range of motion decreased (disease of joint movement)

60+:

  1. Malignant melanoma (skin cancer rises from melancytes)
  2. Anaemia (lack of blood)
  3. Asthenia (weakness)
  4. Fatigue (feeling of tiredness)
  5. Plasma cell myeloma (cancer that begins in plasma cells)
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Blood glucose increased
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Dizziness

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 34 people, 77.27%
  2. High Blood Pressure: 8 people, 18.18%
  3. Anaemia (lack of blood): 6 people, 13.64%
  4. Pain: 5 people, 11.36%
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 11.36%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 11.36%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.09%
  8. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 6.82%
  9. Hypokalemia (low potassium): 3 people, 6.82%
  10. Constipation: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Melphalan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lipitor and Melphalan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Melphalan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Melphalan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium and melphalan (the active ingredients of Lipitor and Melphalan, respectively), and Lipitor and Melphalan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: